Activity of airway antimicrobial peptides against cystic fibrosis pathogens

Andrea Cabak1, Gisela Hovold1, Ann-Cathrine Petersson2

  • 1Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, BMC B14, Sölvegatan 19, S-221 84 Lund, Sweden.

Pathogens and Disease
|August 29, 2020
PubMed

Insights

Airway antimicrobial peptides show varying activity against cystic fibrosis pathogens. Achromobacter xylosoxidans is more resistant than Pseudomonas aeruginosa, potentially due to differences in bacterial surface charge.

Area of Science:

  • Innate immunity
  • Microbiology
  • Host-pathogen interactions

Background:

  • Antimicrobial peptides (AMPs) are crucial for innate host defense against microbes.
  • Cystic Fibrosis (CF) patients are susceptible to infections by pathogens like Pseudomonas aeruginosa, Achromobacter xylosoxidans, and Stenotrophomonas maltophilia.
  • Understanding AMP activity against these CF pathogens is vital for developing new treatments.

Purpose of the Study:

  • To assess the activity of key airway antimicrobial peptides against common and emerging CF pathogens.
  • To compare the susceptibility of Pseudomonas aeruginosa, Achromobacter xylosoxidans, and Stenotrophomonas maltophilia to AMPs.
  • To investigate the role of bacterial cell surface charge in AMP resistance.

Main Methods:

  • Utilized clinical isolates of P. aeruginosa, A. xylosoxidans, and S. maltophilia from CF patients.
  • Evaluated antimicrobial activity using radial diffusion assays and viable bacterial counts.
  • Assessed bacterial cell surface zeta potential to determine net surface charge.

Main Results:

  • Achromobacter xylosoxidans exhibited the highest resistance to tested antimicrobial peptides.
  • Pseudomonas aeruginosa demonstrated the greatest susceptibility to antimicrobial peptides.
  • A significantly more negative surface zeta potential was observed in P. aeruginosa compared to A. xylosoxidans.

Conclusions:

  • Bacterial surface charge significantly influences susceptibility to antimicrobial peptides.
  • A. xylosoxidans represents a more challenging target for antimicrobial peptides than P. aeruginosa in CF infections.
  • These findings highlight the need for tailored therapeutic strategies against specific CF pathogens.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
334
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
605
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
337